Xanthone Derivatives Enhance the Therapeutic Potential of Neomycin against Polymicrobial Gram-Negative Bacterial Infections
- 31 January 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (2) , 527-540
Abstract
Gram-negative bacterial infections are difficult to manage as many antibiotics are ineffective owing to the presence of impermeable bacterial membranes. Polymicrobial infections pose a serious threat due to the inadequate efficacy of available antibiotics, thereby necessitating the administration of antibiotics at higher doses. Antibiotic adjuvants have emerged as a boon as they can augment the therapeutic potential of available antibiotics. However, the toxicity profile of antibiotic adjuvants is a major hurdle in clinical translation. Here, we report the design, synthesis, and biological activities of xanthone-derived molecules as potential antibiotic adjuvants. Our SAR studies witnessed that the p-dimethylamino pyridine-derivative of xanthone (X8) enhances the efficacy of neomycin (NEO) against Escherichia coli and Pseudomonas aeruginosa and causes a synergistic antimicrobial effect without any toxicity against mammalian cells. Biochemical studies suggest that the combination of X8 and NEO, apart from inhibiting protein synthesis, enhances the membrane permeability by binding to lipopolysaccharide. Notably, the combination of X8 and NEO can disrupt the monomicrobial and polymicrobial biofilms and show promising therapeutic potential against a murine wound infection model. Collectively, our results unveil the combination of X8 and NEO as a suitable adjuvant therapy for the inhibition of the Gram-negative bacterial infections.Keywords
Funding Information
- Indian Council of Medical Research
- Department of Biotechnology, Ministry of Science and Technology, India (46214)
- Regional Centre for Biotechnology
This publication has 51 references indexed in Scilit:
- Polymicrobial wound infections: Pathophysiology and current therapeutic approachesInternational Journal of Pharmaceutics, 2014
- On the essentiality of lipopolysaccharide to Gram-negative bacteriaCurrent Opinion in Microbiology, 2013
- Xanthone derivatives could be potential antibiotics: virtual screening for the inhibitors of enzyme I of bacterial phosphoenolpyruvate-dependent phosphotransferase systemThe Journal of Antibiotics, 2013
- Biofilms: do they affect wound healing?International Wound Journal, 2010
- Dynamic Behavior of Salmonella‐Induced Membrane Tubules in Epithelial CellsTraffic, 2008
- Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: Impending synergistic agentsBioorganic & Medicinal Chemistry Letters, 2008
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Epidermal barrier formation and recovery in skin disordersJournal of Clinical Investigation, 2006
- Evolutionary optimization of fluorescent proteins for intracellular FRETNature Biotechnology, 2005
- Bacterial biofilms: from the Natural environment to infectious diseasesNature Reviews Microbiology, 2004